Our top resource picks

All resources

Filters
  • Clear filters
Resource Image
Article

Key considerations when patenting gene editors in Europe

We set out the key things for innovators and applicants to consider when patenting gene editors in Europe.
Resource Image
GJE News

GJE receives double Gold award in IAM Patent 1000 2025 rankings

GJE is delighted to have been recognised with the highest possible Gold ranking in the IAM Patent 1000...
Resource Image
Legal Update

Trade Mark Law & Practice at a Glance – May 2025

UKIPO update Series marks to be abolished As a result of the second transformation consultation by the UKIPO,...
Resource Image
Event

Guardians of innovation: Protecting brand value to grow a business

Date: Wednesday 4 June 2025Time: 16:00 - 18:00Venue: Paddington Works, 8 Hermitage Street, Paddington, London W2 1BERegistrations: Book...
Resource Image
Article

Key considerations when patenting gene therapies in Europe

Technology review The impact of gene therapies has been revolutionary to the treatment of genetic disorders and diseases....
Resource Image
Event

IP & Export: Protecting your innovations in a digital world

Join us on 5 June 2025 for an online masterclass helping UK businesses protect their innovations and trade...
Resource Image
Legal Update

Patent Law & Practice at a Glance – May 2025

Read our May 2025 patent law update, including updates from the UK, the European Patent Office (EPO) and...
Resource Image
Article

Dapagliflozin: UK court reaffirms plausibility standard despite G 2/21

In Generics, Teva & Glenmark v AstraZeneca, the High Court restated how inventive step and sufficiency are assessed...
Resource Image
Article

Key considerations when patenting bispecific antibodies in Europe

Technology overview Bispecific monoclonal antibodies (BsAbs) are antibody constructs that create additional strategies in designing therapeutic avenues due...